Delivery Order SPE2DB20D9127-SPE2DB25FPQS7
Award Date 6/4/25
Potential Completion Date 6/26/25
Potential Value $53K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $52,627.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TYSABRI 300 mg/15 mL vials. This firm fixed-price delivery order, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, represents a specific procurement action under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Tysabri 300 mg/15 ml vials. The contract, valued at $5,262.76 with a firm fixed-price arrangement, is scheduled for completion by August 18, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete directly in the open federal marketplace despite its small...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,788.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Tysabri 300 mg/15 ml vials. This firm fixed-price delivery order, awarded on June 2, 2025, with an ultimate completion date of June 24, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group is executing this order under its existing Indefinite Delivery...
- The Defense Logistics Agency issued a delivery order valued at $21,483.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TYSABRI 300 mg/15 ml vials. This firm fixed-price delivery order, awarded on November 20, 2025, with an ultimate completion date of December 12, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,262.76 to DMS Pharmaceutical Group Inc. on August 18, 2025, for the supply of TYSABRI 300 mg/15 ml vials. This firm fixed-price delivery order is scheduled for completion by September 9, 2025, with performance taking place at the vendor's facility in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $41,265.44 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Tysabri 300 mg/15 ml vials over a period ending on May 15, 2024. This delivery order was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- On June 16, 2025, the Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $21,051.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, with an ultimate completion date of July 9, 2025, is for the supply of TYSABRI 300 mg/15 ml vials. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $52,627.70 firm fixed-price delivery order from the Defense Logistics Agency on September 4, 2025, for TYSABRI 300 mg/15 ml vials. The contract, with an ultimate completion date of September 25, 2025, carries no set-aside designation and represents performance at the company's Park Ridge, Illinois location. This delivery order falls under DMS Pharmaceutical Group's...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Tysabri 300 mg/15 ml vials. The contract, valued at $21,051.08 with a firm fixed-price structure, was executed on September 16, 2025, with an ultimate completion date of October 7, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,158.18 order is for TYSABRI 300 MG/15 ML VIAL 15ML, a biologic medication. The order has a completion date of July 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...